Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A Nomarski image of a live zebrafish embryo at 16.5 hours post-fertilization. The rainbow effect was created by slightly pulling out the differential interference contrast slider. Meng et al. and Doyon et al. demonstrate targeted genetic modification of the zebrafish germ line using zinc-finger nucleases. (pp 695 and 702) Credit: Sharon L. Amacher
The heparin scare highlights the need not only for more effective systems of adverse event reporting and product tracking, but also for drug makers to tighten scrutiny of their suppliers.
Fred Kavli is a visionary philanthropist who began selling wood briquettes in wartime Norway and is now investing his fortune in keeping blue-sky research alive.
Despite tightened legislation against animal rights extremism, activists are increasing attacks on academics and researchers in big pharma. How much of a threat do they pose to researchers working in biotech? Brady Huggett investigates.
The discovery of a contaminant in batches of heparin throws into stark relief the difficulties, not only for the US Food and Drug Administration, but also for international regulatory agencies, to ensure the safety and quality of active pharmaceutical ingredients.
The heparin safety crisis sends a strong signal that urgent changes in regulatory and manufacturing oversight are needed to ensure the safety of the global drug supply.
Analysis of the transgenic papaya genome sequence suggests that transgenes generally stay put following integration and can achieve stable expression level from generation to generation.